Literature DB >> 633081

Responses of heart ornithine decarboxylase and adrenal catecholamines to methadone and sympathetic stimulants in developing and adults rats.

D L Bareis, T A Slotkin.   

Abstract

Sympathetic stimulation elevates heart ornithine decarboxylase (ODC) activity in adult rats, an effect which is followed by cardiac hypertrophy. In developing animals, adrenergic agonists play a role in cardiac growth and differentiation. Methadone administration to adult rats stimulated heart ODC, and this stimulation could be blocked by the sympatholytic agents chlorisondamine, reserpine or propranolol, suggesting that the effect is mediated via central stimulation of sympathetic nerves. With repeated methadone administration, tolerance developed to the heart ODC stimulation by methadone, eventually resulting in decreased heart ODC accompanied by deficits in heart weight. The sensitivity of the mature heart and adrenal medulla to the sympathetic stimulants insulin, nicotine or isoproterenol was virtually unchanged during long-term methadone administration, indicating that tolerance of the heart ODC response to methadone did not result from subsensitivity of the efferent sympathetic pathway or the heart ODC response system. In normally developing rats, responses to insulin-induced reflex stimulation of sympathetic nerve supplies to the heart and adrenal medulla did not occur until 8 days of postnatal age; however, daily treatment of pups with methadone begun the day after birth accelerated the development of functiona heart and adrenal medullary responses to insulin such that responses were obtained by 4 days of age. The cardiac responses to nicotine developed somewhat differently, with significant ODC stimulation first appearing at 12 days in controls and at 8 days in methadone-treated pups. In the adrenal gland, a tissue in which responses to nicotine do not depend on an intact nerve supply a catecholamine secretory response to nicotine was observed at 4 days of age in controls. These data suggest that methadone treatment accelerates the development of functional sympathetic innervation of heart and adrenal medulla, with resultant abnormalities in cardiac muscle growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 633081

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  6 in total

1.  Terbutaline impairs the development of peripheral noradrenergic projections: potential implications for autism spectrum disorders and pharmacotherapy of preterm labor.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Neurotoxicol Teratol       Date:  2012-07-16       Impact factor: 3.763

2.  Localisation of chromogranin A and B, met-enkephalin-arg6-gly7-leu8 and PGP9.5-like immunoreactivity in the developing and adult rat adrenal medulla and extra-adrenal chromaffin tissue.

Authors:  C Kent; R E Coupland
Journal:  J Anat       Date:  1989-10       Impact factor: 2.610

3.  beta 2-Adrenoceptors regulate induction of myocardial ornithine decarboxylase in mice in vivo.

Authors:  J G Copeland; D F Larson; W R Roeske; D H Russell; J R Womble
Journal:  Br J Pharmacol       Date:  1982-03       Impact factor: 8.739

4.  Relationship between the in-situ activity of ornithine decarboxylase and contractile function of the rabbit papillary muscle.

Authors:  R J Boucek; R D Olson; R C Boerth
Journal:  Basic Res Cardiol       Date:  1983 Nov-Dec       Impact factor: 17.165

5.  Presynaptic and postsynaptic contributions to ontogeny of sympathetic control of heart rate in the pre-weanling rat.

Authors:  F J Seidler; T A Slotkin
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

6.  Adrenomedullary function in the neonatal rat: responses to acute hypoxia.

Authors:  F J Seidler; T A Slotkin
Journal:  J Physiol       Date:  1985-01       Impact factor: 5.182

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.